All the following factors—ITGB1 expression, CA19-9, operation time, operation type, bleeding volume, vascular invasion, neural invasion, lymph node metastasis, tumor diameter, and T factor—were significantly associated with poor prognosis of pancreatic cancer. This evidence concerns the gene ITGB1 and metastatic malignant neoplasm in the lymph nodes.